215 related articles for article (PubMed ID: 29158809)
21. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
22. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
Chen HY; Wang X; Zhang H; Liu XB; Tan CL
World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
[TBL] [Abstract][Full Text] [Related]
23. A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma.
Wu LX; Wang XY; Xu KQ; Lin YL; Zhu WY; Han L; Shao YT; Zhou HY; Jiang H; Hang JJ; Yang XG
J Cancer; 2019; 10(26):6673-6680. PubMed ID: 31777596
[TBL] [Abstract][Full Text] [Related]
24. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
25. Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries.
Li Z; Zhang X; Sun C; Li Z; Fei H; Zhao D
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675442
[TBL] [Abstract][Full Text] [Related]
26. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
27. Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings.
Li D; Wang L; Cai W; Liang M; Ma X; Zhao X
Eur J Radiol; 2022 Jun; 151():110313. PubMed ID: 35447500
[TBL] [Abstract][Full Text] [Related]
28. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System.
Ren H; Wu CR; Qiu GT; Zhang LP; Aimaiti S; Wang CF
J Oncol; 2020; 2020():9093729. PubMed ID: 33014058
[TBL] [Abstract][Full Text] [Related]
29. Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
Zhang LP; Ren H; Du YX; Zheng XH; Zhang ZM; Wang CF
World J Gastrointest Surg; 2021 Mar; 13(3):279-302. PubMed ID: 33796216
[TBL] [Abstract][Full Text] [Related]
30. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
[TBL] [Abstract][Full Text] [Related]
31. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
32. Refining the American Joint Committee on Cancer Staging Scheme For Resectable Pancreatic Ductal Adenocarcinoma Using Recursive Partitioning Analysis.
Jiang Y; Su Y; Chen Y; Li Z
J Cancer; 2017; 8(14):2765-2773. PubMed ID: 28928865
[No Abstract] [Full Text] [Related]
33. Usefulness of Inflammation-Based Prognostic Scores in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma.
Hong S; Hwang DW; Lee JH; Song KB; Lee W; Kwak BJ; Park Y; Kim SC
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945079
[TBL] [Abstract][Full Text] [Related]
34. Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.
Gan W; Yi Y; Fu Y; Huang J; Lu Z; Jing C; Fan J; Zhou J; Qiu S
J Cancer; 2018; 9(1):148-156. PubMed ID: 29290780
[No Abstract] [Full Text] [Related]
35. Presence of tumor deposits is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma.
Liang Y; Chang S; Guo H; Man Q; Zang F; Gao S
Am J Cancer Res; 2023; 13(5):1970-1984. PubMed ID: 37293176
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
[No Abstract] [Full Text] [Related]
37. Validation of a prognostic nomogram in patients undergoing resection for pancreatic ductal adenocarcinoma in a UK tertiary referral centre.
Clark EJ; Taylor MA; Connor S; O'Neill R; Brennan MF; Garden OJ; Parks RW
HPB (Oxford); 2008; 10(6):501-5. PubMed ID: 19088940
[TBL] [Abstract][Full Text] [Related]
38. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
Chen YT; Huang ZP; Zhou ZW; He MM
Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
[TBL] [Abstract][Full Text] [Related]
39. A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenectomy.
Li HB; Zhou J; Zhao FQ
Med Sci Monit; 2018 Sep; 24():6313-6321. PubMed ID: 30198517
[TBL] [Abstract][Full Text] [Related]
40. The Prognostic Value of Preoperative Geriatric Nutritional Risk Index in Patients with Pancreatic Ductal Adenocarcinoma.
Hu SP; Chen L; Lin CY; Lin WH; Fang FQ; Tu MY
Cancer Manag Res; 2020; 12():385-395. PubMed ID: 32021451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
